Yong-Hun et al. [29] found that FBLN5 initiated EMT through a matrix metalloproteinase-dependent mechanism and enhanced the extent of EMT induced by TGF-β-induced breast epithelial cells, suggesting that FBLN5 had tumor-promoting functions in breast cancer. The gene discussed is TGFB1; the disease is breast carcinoma.